ESMO 2021 Efficacy and Safety of Tepotinib in Patients With Advanced Age: VISION Subgroup Analysis of Pts With MET Exon 14 Skipping NSCLC

34 views
October 20, 2021
0 Comments
Login to view comments. Click here to Login
Videos